?:authorAffiliation
|
-
[\'Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain.\', \'Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.\', \'Institute for Integrative Systems Biology (I2SysBio), Universitatde Valencia-CSIC, 46980, Valencia, Spain.\', \'Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain; Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.\', \'Department of Genomics and Proteomics, Instituto de Biomedicina de Valencia (IBV-CSIC) and CIBER de Enfermedades Raras (CIBERER-ISCIII), Valencia, Spain; Decoy-SARS-CoV-2 Study Group from the Institute of Biomedicine of Valencia (Group Members List in Acknowledgements Section), Spain.\', \'Medical Intensive Care Unit, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.\', \'Pneumology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.\', \'Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain. Electronic address: jesus.rodriguez@uv.es.\', \'Institute for Integrative Systems Biology (I2SysBio), Universitatde Valencia-CSIC, 46980, Valencia, Spain. Electronic address: ron.geller@uv.es.\', \'Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain; Microbiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain. Electronic address: david.navarro@uv.es.\']
|